ArticleThe American journal of case reports2025
Time Course of Serum Dextromethorphan Concentrations in a Case of Serotonin Syndrome After Massive Overdose.
Article in The American journal of case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Dextromethorphan (DXM) inhibits serotonin reuptake when taken in large doses, potentially causing serotonin syndrome, which is likely life-threatening. Despite a few reports of serotonin syndrome after DXM overdose, no case report has provided a detailed analysis of serial blood DXM levels alongside the clinical course. Here, we present a case with serial measurements of blood DXM levels taken over time. CASE REPORT A 24-year-old man with bipolar disorder and attention-deficit/hyperactivity disorder, treated with trazodone and methylphenidate, ingested 300 mg of DXM (4.6 mg/kg). After 10 hours, he exhibited agitation, confusion, and impaired consciousness. On admission, his DXM blood level was 398 ng/mL; trazodone and methylphenidate levels were both <1 ng/mL. He developed serotonin syndrome with spontaneous clonus and seizures, requiring diazepam, sedation, intubation, and ventilation. By hospital day 3, the DXM level decreased to 26 ng/mL; by day 5, it was undetectable. Despite clinical stabilization and extubation by day 4, hallucinations and delusions persisted. After receiving a diagnosis of acute and transient psychotic disorder on day 9, he was transferred to the psychiatry department. With oral therapy and electroconvulsive therapy, he improved by day 33. The final diagnosis was substance/medication-induced psychotic disorder. CONCLUSIONS Our case report provides a detailed timeline of blood DXM concentrations along with the clinical course in a patient with serotonin syndrome after an acute overdose. The serial measurements support the importance of symptom-focused monitoring to guide treatment decisions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.